Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children.
Lighter J, Rigaud M, Huie M, Peng CH, Pollack H. Lighter J, et al. Int J Tuberc Lung Dis. 2009 Jun;13(6):731-6. Int J Tuberc Lung Dis. 2009. PMID: 19460249
DESIGN: IP-10 levels were obtained after whole blood stimulation with M. tuberculosis-specific antigens in 127 children. IP-10 results were evaluated upon gradations of exposure risk to M. tuberculosis and correlation with tuberculin skin test and an interferon-gamm …
DESIGN: IP-10 levels were obtained after whole blood stimulation with M. tuberculosis-specific antigens in 127 children. IP-10 result …
Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
Sitnitskaya Y, Rochford G, Rigaud M, Essajee S, Pollack H, Krasinski K, Borkowsky W. Sitnitskaya Y, et al. Clin Infect Dis. 2001 Jul 1;33(1):e3-7. doi: 10.1086/320877. Epub 2001 Jun 6. Clin Infect Dis. 2001. PMID: 11389511
Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.
Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Lighter J, et al. Pediatrics. 2009 Jan;123(1):30-7. doi: 10.1542/peds.2007-3618. Pediatrics. 2009. PMID: 19117857
The concordance between tuberculin skin test and QuantiFERON-TB Gold In-Tube test results was calculated, and the results were analyzed according to the likelihood of exposure to M tuberculosis. ...Positive QuantiFERON-TB Gold In-Tube test results were associated with incr …
The concordance between tuberculin skin test and QuantiFERON-TB Gold In-Tube test results was calculated, and the results were analyzed acco …
Correlation between HIV-Specific CD8 cell production of interferon- gamma and plasma levels of HIV RNA in perinatally infected pediatric populations.
Borkowsky W, Zhan MX, Chen SH, Ilmet T, Kaul A, Chandwani S, Rigaud M, Essajee S, Gruber C, Freedman A, Krasinski K. Borkowsky W, et al. J Infect Dis. 2004 Aug 15;190(4):722-6. doi: 10.1086/422757. Epub 2004 Jul 14. J Infect Dis. 2004. PMID: 15272400
Diagnosing childhood tuberculosis: traditional and innovative modalities.
Lighter J, Rigaud M. Lighter J, et al. Curr Probl Pediatr Adolesc Health Care. 2009 Mar;39(3):61-88. doi: 10.1016/j.cppeds.2008.12.003. Curr Probl Pediatr Adolesc Health Care. 2009. PMID: 19215860 Review. No abstract available.
Thrombocytopenia in children infected with human immunodeficiency virus: long-term follow-up and therapeutic considerations.
Rigaud M, Leibovitz E, Quee CS, Kaul A, Nardi M, Pollack H, Lawrence R, DiJohn D, Krasinski K, Karpatkin M, et al. Rigaud M, et al. J Acquir Immune Defic Syndr (1988). 1992;5(5):450-5. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1560341
Natural history of HIV infected pediatric long-term or slow progressor population after the first decade of life.
Ofori-Mante JA, Kaul A, Rigaud M, Fidelia A, Rochford G, Krasinski K, Chandwani S, Borkowsky W. Ofori-Mante JA, et al. Pediatr Infect Dis J. 2007 Mar;26(3):217-20. doi: 10.1097/01.inf.0000254413.11246.e1. Pediatr Infect Dis J. 2007. PMID: 17484217
Streptococcus pneumoniae in human immunodeficiency virus type 1-infected children.
Gesner M, Desiderio D, Kim M, Kaul A, Lawrence R, Chandwani S, Pollack H, Rigaud M, Krasinski K, Borkowsky W. Gesner M, et al. Pediatr Infect Dis J. 1994 Aug;13(8):697-703. doi: 10.1097/00006454-199408000-00004. Pediatr Infect Dis J. 1994. PMID: 7970969
Thirty-year Perspective of the Long-term Survival, CD4 Percentage and Social Achievements of Perinatally HIV-infected Children as a Function of Their Birth Era.
Vuppula S, Tyungu D, Kaul A, Chandwani S, Rigaud M, Borkowsky W. Vuppula S, et al. Among authors: rigaud m. Pediatr Infect Dis J. 2017 Feb;36(2):198-201. doi: 10.1097/INF.0000000000001393. Pediatr Infect Dis J. 2017. PMID: 27824723
Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy.
Rigaud M, Borkowsky W, Muresan P, Weinberg A, Larussa P, Fenton T, Read JS, Jean-Philippe P, Fergusson E, Zimmer B, Smith D, Kraimer J; Pediatrics AIDS Clinical Trials Group P1006 Team. Rigaud M, et al. J Infect Dis. 2008 Oct 15;198(8):1123-30. doi: 10.1086/592050. J Infect Dis. 2008. PMID: 18752430 Free PMC article. Clinical Trial.
238 results
Jump to page
Feedback